Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03436290 · ClinicalTrials.gov registry record · NA

Surgery for Cancer With Option of Palliative Care Expert

A NA study of Cancer, sponsored by Vanderbilt University Medical Center.

Active
Registry status
NA
Development phase
236
Enrollment target
1
Study location

NCT03436290: Active NA study of Cancer, sponsored by Vanderbilt University Medical Center.

NCT03436290 is a NA study of Cancer that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 236 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03436290, a NA study of Cancer, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
236 participants
Enrollment target
1
Study location

Study Summary

Frequently people diagnosed with cancer experience physical and emotional symptoms during the course of their disease. These symptoms can be very distressing to both the patient and the family members. The study doctor wants to know if the introduction of a team of clinicians that specialize in the lessening of many of these distressing symptoms may improve your overall care. This team of clinicians is called the palliative care team and they focus on ways to improve your pain and other symptom management (i.e. shortness of breath, fatigue, anxiety, etc.) and to assist you and your family in coping with the emotional, social, and spiritual issues associated with your diagnosis. The team consists of physicians, advanced practice nurses, case managers, and nurses who have been specially trained in the care of patients facing serious illness. This research study is being done because although many people with cancer receive palliative care late in the course of their illness, the study team thinks palliative care may be more useful when it is started earlier and in this case before surgery. The main purpose of this study is to compare two types of care -usual surgery and cancer care and usual surgery and cancer care with comprehensive palliative care services to see which is better for improving the experience of patients and families with cancer.

Primary Outcome

FACT-Gastric Trial Outcome Index (TOI) is an efficient summary index of physical/functional outcomes and is comprised of two subscales from the FACT-Gastric Score: the physical wellbeing subscale (7 questions) and the functional wellbeing scale (7 questions). Each question uses a 5-point Likert scale ranging from 0 (Not at all) to 4 (Very much). Total scores on the FACT-TOI range from 0-56. The higher the score, the better the quality of life.

Conditions Studied

Interventions

  • BEHAVIORAL Palliative Care Intervention

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2018-03-01
Est. Completion 2026-11
Phase NA

What the registry record for NCT03436290 still lists

NCT03436290 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Palliative Care Intervention is the first listed.

NCT03436290 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT03436290 about?

NCT03436290 is a clinical study titled "Surgery for Cancer With Option of Palliative Care Expert". Frequently people diagnosed with cancer experience physical and emotional symptoms during the course of their disease. These symptoms can be very distressing to both the patient and the family members. The study doctor wants to know if the introduction of a team of clinicians that specialize in the ...

What is the current status of trial NCT03436290?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 236 participants. The study started on 2018-03-01. Estimated completion is 2026-11.

What conditions does trial NCT03436290 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03436290?

The interventions under investigation include: Palliative Care Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03436290?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03436290 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03436290's enrollment target sits among peer trials

236 218th of 615 higher than 398 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04995341 · 236 participants · NA

    Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

  • NCT05822362 · 236 participants · Phase 2

    CBD for Individuals at Risk for Alzheimer's Disease

  • NCT06200103 · 236 participants · Phase 2

    Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

  • NCT06494072 · 236 participants · Phase 4

    Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03436290, the US trial registry maintained by the National Library of Medicine. NCT03436290 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.